HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lacomis, D. Articles by Smith, T. W. Search for Related Content PubMed PubMed Citation Articles by Lacomis, D. Articles by Smith, T. W.

Myopathy in the elderly

Evaluation of the histopathologic spectrum and the accuracy of clinical diagnosis

Departments of Neurology and Pathology (Neuropathology), University of Massachusetts Medical Center, Worcester, MA.

We undertook a retrospective clinicopathologic study to ascertain the spectrum of histopathologic muscle biopsy changes in the elderly thought to have a myopathy, and to determine the accuracy of clinical diagnosis of myopathy in the elderly compared with a younger control population. We compared muscle histology and case histories, as well as EMG and creatine kinase (CK) data, obtained over 10 years from 77 consecutive patients aged 65 years or older (75 ± 6, x ± SD; group 1) with those from 104 patients aged 30 to 50 years (group 2). Prominent myopathic features were present in 42% (group 1) versus 51% (group 2) of all biopsies. Neurogenic changes (17% versus 9%, p < 0.04) and type II fiber atrophy (22% versus 6%, p < 0.0005) were more common in the elderly, whereas normal findings tended to be less frequent (19% versus 35%). In at least 68% of patients in both groups with the histologic diagnosis of myopathy, either the CK was elevated or the EMG was consistent with that diagnosis. Our study indicates that (1) the spectrum of histopathologic changes in the two groups differs because of a higher frequency of neurogenic change and type II atrophy in the elderly, and (2) the accuracy of clinical diagnosis of myopathy in the elderly approximates that in a younger population.

Address correspondence and reprint requests to Dr. David Lacomis, Neurology Department, University of Massachusetts Medical Center, 55 Lake Avenue N, Worcester, MA 01655.

Received June 10, 1992. Accepted for publication in final form August 27, 1992.

This article has been cited by other articles:

				J. A. Van Gerpen, J. E. Ahlskog, Y. Ben-Shlomo, J. Head, A. Lees, P. T. Donnan, D. T. Steinke, P. G. Davey, and T. M. MacDonald Selegiline and mortality in subjects with Parkinson's disease: A longitudinal community study Neurology, July 24, 2002; 57(2): 368 - 370. [Full Text] [PDF]

				T Umapathi, V Chaudhry, D Cornblath, D Drachman, J Griffin, and R Kuncl Head drop and camptocormia J. Neurol. Neurosurg. Psychiatry, July 1, 2002; 73(1): 1 - 7. [Full Text] [PDF]

				P.T. Donnan, D.T. Steinke, C. Stubbings, P.G. Davey, and T.M. MacDonald Selegiline and mortality in subjects with Parkinson's disease: A longitudinal community study Neurology, December 26, 2000; 55(12): 1785 - 1789. [Abstract] [Full Text] [PDF]

				R. G. Miller The Effects of Aging Upon Nerve and Muscle Function and Their Importance for Neurorehabilitation Neurorehabil Neural Repair, January 1, 1995; 9(3): 175 - 181. [Abstract] [PDF]